FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W10841170> ?p ?o ?g. }

• W10841170 endingPage "3767" @default.
• W10841170 startingPage "3758" @default.
• W10841170 abstract "The effect of A02131–1 [3-(5′-hydroxymethyl-2′-furyl)-1-benzyl thieno (3,2-c)pyrazole], a cGMP-specific phosphodiesterase (PDE) inhibitor, on platelet function was investigated. The compound was found to inhibit the aggregation of and adenosine triphosphate (ATP) release from human platelet-rich plasma and washed platelets that were induced by aggregation inducing drugs such as arachidonic acid (AA), collagen, U46619, platelet-activating factor (PAF), adenosine diphosphate (ADP) and A23187, and the inhibitory effect was concentration-dependent. A02131–1 also disaggregated the performed platelet aggregates induced by these inducers. Thromboxane B2 (TXB2) formations caused by collagen, PAF, ADP, and A23187 were inhibited by A02131–1 at concentrations that did not affect the AA-induced formation of TXB2 and prostaglandin D2 (PGD2). A02131–1 suppressed both the generation of inositol 1,4,5- triphosphate (IP3) and the increase of intracellular Ca2+ concentration stimulated by these aggregation inducers. A02131–1 was shown to increase the cAMP and cGMP levels in platelets and the extent was found to be dependent on concentration as well as time. A02131–1 increased the cAMP level much more slowly than the cGMP level. Activities of adenylate cyclase, guanylate cyclase, and PDEs (type I and III) were not altered by A02131–1. However, the activity of cGMP-specific PDE (type V) was inhibited by A02131–1. The antiplatelet aggregation activity and the effect on raising cAMP level of A02131–1 were both potentiated by prostaglandin E1 (PGE1). In the mouse tail bleeding test, A02131–1 was clearly shown to be more effective than dipyridamole in prolonging the tail bleeding time of conscious mice. These data indicate that A02131–1 is a cGMP-specific PDE (type V) inhibitor in human platelets." @default.
• W10841170 created "2016-06-24" @default.
• W10841170 creator A5006690951 @default.
• W10841170 creator A5020322982 @default.
• W10841170 creator A5065881040 @default.
• W10841170 creator A5070600064 @default.
• W10841170 date "1996-05-01" @default.
• W10841170 modified "2023-10-18" @default.
• W10841170 title "Inhibition of platelet function by A02131-1, a novel inhibitor of cGMP- specific phosphodiesterase, in vitro and in vivo" @default.
• W10841170 cites W1491490245 @default.
• W10841170 cites W1505892934 @default.
• W10841170 cites W1535668052 @default.
• W10841170 cites W1566160921 @default.
• W10841170 cites W1566213869 @default.
• W10841170 cites W1837479159 @default.
• W10841170 cites W1940750159 @default.
• W10841170 cites W1948702918 @default.
• W10841170 cites W1966716801 @default.
• W10841170 cites W1968133040 @default.
• W10841170 cites W1973657843 @default.
• W10841170 cites W1993210005 @default.
• W10841170 cites W1998490733 @default.
• W10841170 cites W2007737411 @default.
• W10841170 cites W2008251723 @default.
• W10841170 cites W2010893307 @default.
• W10841170 cites W2022736712 @default.
• W10841170 cites W2027704731 @default.
• W10841170 cites W2036284239 @default.
• W10841170 cites W2036540567 @default.
• W10841170 cites W2052385160 @default.
• W10841170 cites W2061755142 @default.
• W10841170 cites W2070370694 @default.
• W10841170 cites W2071331983 @default.
• W10841170 cites W207373148 @default.
• W10841170 cites W2076934335 @default.
• W10841170 cites W2079958737 @default.
• W10841170 cites W2081330336 @default.
• W10841170 cites W2081480546 @default.
• W10841170 cites W2087178261 @default.
• W10841170 cites W2092004001 @default.
• W10841170 cites W2141260882 @default.
• W10841170 cites W2165539002 @default.
• W10841170 cites W2189293602 @default.
• W10841170 cites W2281130025 @default.
• W10841170 cites W2327269495 @default.
• W10841170 cites W2410437060 @default.
• W10841170 cites W2415768575 @default.
• W10841170 cites W2416680393 @default.
• W10841170 cites W2417379444 @default.
• W10841170 cites W2419963662 @default.
• W10841170 cites W2474472391 @default.
• W10841170 cites W2167223166 @default.
• W10841170 cites W2591855227 @default.
• W10841170 doi "https://doi.org/10.1182/blood.v87.9.3758.bloodjournal8793758" @default.
• W10841170 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8611701" @default.
• W10841170 hasPublicationYear "1996" @default.
• W10841170 type Work @default.
• W10841170 sameAs 10841170 @default.
• W10841170 citedByCount "12" @default.
• W10841170 countsByYear W108411702014 @default.
• W10841170 countsByYear W108411702022 @default.
• W10841170 crossrefType "journal-article" @default.
• W10841170 hasAuthorship W10841170A5006690951 @default.
• W10841170 hasAuthorship W10841170A5020322982 @default.
• W10841170 hasAuthorship W10841170A5065881040 @default.
• W10841170 hasAuthorship W10841170A5070600064 @default.
• W10841170 hasBestOaLocation W108411701 @default.
• W10841170 hasConcept C126322002 @default.
• W10841170 hasConcept C134018914 @default.
• W10841170 hasConcept C150903083 @default.
• W10841170 hasConcept C170493617 @default.
• W10841170 hasConcept C180526460 @default.
• W10841170 hasConcept C181199279 @default.
• W10841170 hasConcept C185592680 @default.
• W10841170 hasConcept C207001950 @default.
• W10841170 hasConcept C2776766087 @default.
• W10841170 hasConcept C2776785769 @default.
• W10841170 hasConcept C2776991684 @default.
• W10841170 hasConcept C2777399203 @default.
• W10841170 hasConcept C2778078955 @default.
• W10841170 hasConcept C2779837120 @default.
• W10841170 hasConcept C2780069284 @default.
• W10841170 hasConcept C2780664492 @default.
• W10841170 hasConcept C2781024287 @default.
• W10841170 hasConcept C2993802102 @default.
• W10841170 hasConcept C55493867 @default.
• W10841170 hasConcept C62826618 @default.
• W10841170 hasConcept C71924100 @default.
• W10841170 hasConcept C86803240 @default.
• W10841170 hasConcept C89560881 @default.
• W10841170 hasConceptScore W10841170C126322002 @default.
• W10841170 hasConceptScore W10841170C134018914 @default.
• W10841170 hasConceptScore W10841170C150903083 @default.
• W10841170 hasConceptScore W10841170C170493617 @default.
• W10841170 hasConceptScore W10841170C180526460 @default.
• W10841170 hasConceptScore W10841170C181199279 @default.
• W10841170 hasConceptScore W10841170C185592680 @default.
• W10841170 hasConceptScore W10841170C207001950 @default.

• next